Skip navigation.

Welcome to SAfAIDS

SAfAIDS news

Strengthening capacity of community leadership to champion HIV response in Swaziland

SAfAIDS in partnership with Khulisa Umntfwana successfully conducted a 2-day training for 30 traditional leaders at ESibayeni Lodge in October 2016. The Traditional Leaders came from 15 chiefdoms in the four regions of Swaziland. SAfAIDS Deputy Director, Khulisa Umntfwana Executive Director and two National Technical Advisory Committee (NTAC) members also participated the training. 

New device can detect viral load in under 30 minutes

LONDON, 11 November 2016 (AVERT) - Viral load testing may become more accessible to millions of people living with HIV in sub-Saharan Africa thanks to a new USB testing stick.

Reducing The Impact of HIV Among Adolescent Girls

GENEVA, 11 November 2016 (UNAIDS) - Around 180 young women and adolescent girls from Malawi, Kenya and Uganda have led a pilot project that aims to strengthen the leadership of young women and adolescent girls in the AIDS response. 

Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

LONDON, 10 November 2016 (aidsmap) - A co-formulation of tenofovir alafenamide (TAF) plus emtricitabine, used with a third antiretroviral drug, maintained viral suppression as well as tenofovir disoproxil fumarate (TDF) plus emtricitabine in older individuals, and was associated with improvements in kidney function and bone density, which may be of greater concern for this group, according to a presentation last week at IDWeek 2016 in New Orleans.

HIV Vaccine Trials a Major Boost to Fight Against AIDS

CAPE TOWN, 9 November 2016 (allAfrica) -  Deputy President Cyril Ramaphosa says the start of HIV vaccine trials are a major boost to the fight against AIDS.

Africa: We Can Lead The Way in Ending AIDS, Malaria and TB

ADDIS ABABA, 1 November 2016 - In September, world leaders pledged nearly US$13 billion to tackle some of the world's deadliest diseases through the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria. In a time of significant global uncertainty and strife, this was a remarkable display of commitment to the health and well-being of the most vulnerable populations on the planet.

Syndicate content